KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Castle Biosciences (CSTL) Retained Earnings: 2018-2025

Historic Retained Earnings for Castle Biosciences (CSTL) over the last 7 years, with Sep 2025 value amounting to -$222.0 million.

  • Castle Biosciences' Retained Earnings fell 5.86% to -$222.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$222.0 million, marking a year-over-year decrease of 5.86%. This contributed to the annual value of -$200.1 million for FY2024, which is 8.36% up from last year.
  • As of Q3 2025, Castle Biosciences' Retained Earnings stood at -$222.0 million, which was down 0.23% from -$221.5 million recorded in Q2 2025.
  • Castle Biosciences' Retained Earnings' 5-year high stood at -$66.8 million during Q1 2021, with a 5-year trough of -$226.0 million in Q1 2025.
  • Its 3-year average for Retained Earnings is -$213.2 million, with a median of -$215.8 million in 2023.
  • As far as peak fluctuations go, Castle Biosciences' Retained Earnings crashed by 77.29% in 2022, and later increased by 8.36% in 2024.
  • Castle Biosciences' Retained Earnings (Quarterly) stood at -$93.8 million in 2021, then plummeted by 71.60% to -$160.9 million in 2022, then crashed by 35.71% to -$218.4 million in 2023, then grew by 8.36% to -$200.1 million in 2024, then fell by 5.86% to -$222.0 million in 2025.
  • Its Retained Earnings stands at -$222.0 million for Q3 2025, versus -$221.5 million for Q2 2025 and -$226.0 million for Q1 2025.